A carregar...
Significant cytostatic effect of everolimus on a gefitinib-resistant anaplastic thyroid cancer cell line harboring PI3KCA gene mutation
We previously demonstrated the efficacy of gefitinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR), on an anaplastic thyroid cancer (ATC) cell line. We also observed that gefitinib was not effective in regulating cell growth in a different ATC cell line that exhibited a...
Na minha lista:
Publicado no: | Mol Clin Oncol |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
D.A. Spandidos
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4471583/ https://ncbi.nlm.nih.gov/pubmed/26137260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.496 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|